Yue Shi

Yue Shi

Auto-generated profile, based on publicly available information

Yue Shi

The First Affiliated Hospital of Jinzhou Medical University, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
Mengyuan FangMengyuan Fang
Mengyuan Fang
WFWenying Fan
Wenying Fan
YSYue Shi
Yue Shi
MIMichael S. Ip
Michael S. Ip
CWCharles Wykoff
Charles Wykoff
SSSRINIVAS R SADDA
SRINIVAS R SADDA

5 April 2019 in Current Eye Research
Verified
Journal Article
Closed access
JHJianyan Huang
Jianyan Huang
TTTudor C. Tepelus
Tudor C. Tepelus
EBElmira Baghdasaryan
Elmira Baghdasaryan
PHPing Huang
Ping Huang
YSYue Shi
Yue Shi
OLOlivia L. Lee
Olivia L. Lee
Purpose: To characterize and correlate guttata severity, Descemet’s membrane thickness (DMT), central cornea thickness (CCT) in corneas with guttae using specular microscopy and spectral-domain optical coherence tomography (SD-OCT) and test the Doheny Image Reading Center (DIRC) specular microscopy-based corneal guttata severity scale. Methods: Forty-nine eyes of 49 patients with guttata and 36 eyes of age-matched of 36 normal controls were enrolled in the study. Three images of the central cornea and four of the peripheral cornea (inferior, superior, nasal and temporal) of each eye were taken using the Konan NSP-9900 specular microscope. A volume scan of the central cornea cross-section was collected on each eye using the Heidelberg Spectralis SD-OCT. The density of endothelial guttata based on specular images was graded on a 0-4 scale and the Descemet’s membrane thickness (DMT) and central corneal thickness (CCT) were manually measured by two trained graders. Results: The DIRC corneal guttata severity scale showed good reproducibility of all corneal endothelial images (weighted Kappa=0.87). Mean DMT was 16.1± 2.4 µm in controls and 25.5 ± 10.9 µm in corneas with guttata (P<0.001). Mean CCT was 552 ± 26 µm in controls and 603 ± 55 µm in corneas with guttata (P<0.001). Guttata severity was significantly correlated with both DMT (r=0.743, P<0.001) and CCT (r=0.569, P<0.001). Age was moderately correlated with DMT (r=0.472, P=0.003) and mildly correlated with guttata severity (r=0.285, P=0.031), but was not correlated with CCT (r=0.058, P=0.681). Guttatta grade 3 corneas displayed increase in DMT and guttata grade 4 was associated with a significant increase in CCT. Conclusions: The DMT and CCT are increased in corneas with guttata. The higher density of guttae is correlated with increased thickness. Specular microscopy combined with SD-OCT can be used as a good approach to assess severity of FECD.

1 January 2024 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
YZYiqi Zhang
Yiqi Zhang
AZAng Zheng
Ang Zheng
YSYue Shi
Yue Shi
HLHeng Lu
Heng Lu
Small nucleolar RNAs (snoRNAs) have robust potential functions and therapeutic value in breast cancer. Herein, we investigated the role SNORA5A in breast cancer. Samples from The Cancer Genome Atlas (TCGA) were reviewed. The transcription matrix and clinical information were analyzed using R software and validated in clinical tissue samples. SNORA5A was significantly down-regulated in breast cancer, and high expression of SNORA5A correlated with a favorable prognosis. High expression of SNORA5A induced a high concentration of tumor-associated macrophages M1 and a low concentration of tumor-associated macrophages M2. Moreover, SNORA5A were clustered in terms related to cancer and immune functions. Possible downstream molecules of SNORA5A were identified, among which TRAF3IP3 was positively correlated with M1 and negatively correlated with M2. The function of TRAF3IP3 in tumor inhibition and its relationship with macrophages in clinical tissue samples were in accordance with bioinformatics analysis results. SNORA5A could regulate macrophage phenotypes through TRAF3IP3 and serves as a potential prognostic marker for breast cancer patients.